Reversion of AHRR Demethylation Is a Quantitative Biomarker of Smoking Cessation
Bibliographic Data
| ID | 15516628 |
|---|---|
| Authors | Robert A Philibert (0000-0001-7822-4977, Behavioral Diagnostics (United States), corresponding author), Robert Philibert, Nancy Hollenbeck (0000-0001-8144-3169, University of Iowa), Eleanor Andersen (Behavioral Diagnostics (United States)), Shyheme McElroy (University of Iowa), Scott Wilson (0000-0003-3510-4240, University of Iowa), Kyra Vercande (University of Iowa), Steven R Beach (0000-0001-8053-7761, University of Georgia), Steven R H Beach, Terry Osborn (Behavioral Diagnostics (United States)), Meg Gerrard (University of Connecticut), Frederick X Gibbons (0000-0003-1205-1481, University of Connecticut), Kai Wang (0000-0002-3784-1378) |
| Year | 2016 |
| Volume | 7 |
| Pages | 55-55 |
| Publication date | 2016-04-06 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2016.00055 |
| PMID | 27092088 |
| OpenAlex | W2324788618 |
| Language | EN |
| Citations received | 1 |
| References cited | 32 |
Smoking is the largest preventable cause of morbidity and mortality in the world. Although there are effective pharmacologic and behavioral treatments for smoking cessation, our inability to objectively quantify smokers' progress in decreasing smoking has been a barrier to both clinical and research efforts. In prior work, we and others have shown that DNA methylation at cg05575921, a CpG residue in the aryl hydrocarbon receptor repressor (AHRR), can be used to determine smoking status and infer cigarette consumption history. In this study, we serially assessed self-report and existing objective markers of cigarette consumption in 35 subjects undergoing smoking cessation therapy, then quantified DNA methylation at cg05575921 at study entry and three subsequent time points. Five subjects who reported serum cotinine and exhaled carbon monoxide verified smoking abstinence for the 3 months prior to study exit averaged a 5.9% increase in DNA methylation at cg05575921 (p < 0.004) over the 6-month study. Although the other 30 subjects did not achieve smoking cessation at the 6-month time point, their self-reported reduction of cigarette consumption (mean = 6 cigarettes/day) was associated with a 2.8% increase DNA methylation at cg05575921 (p < 0.05). Finally, a survey of subjects as they exited the study demonstrated strong support for the clinical use of epigenetic biomarkers. We conclude that AHRR methylation status is a quantifiable biomarker for progress in smoking cessation that could have substantial impact on both smoking cessation treatment and research
Abstinence · Biology · Biomarker · Cotinine · CpG site · DNA methylation · Epigenetics · Gene · Gene expression · Methylation · Nicotine · Pathology · Psychiatry · Smoking cessation · Cannabis and Cannabinoid Research · Epigenetics and DNA Methylation · Medicine · Smoking Behavior and Cessation · Genetics · Internal Medicine · Oncology
| Unique citing works | 1 |
|---|---|
| Citations per year | 0,2 |
| Citation span | 2021 - 2021 (1) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |